Dynamic Changes of Urine Proteome in Rat Models Inoculated with Two Different Hepatoma Cell Lines
Open Access
- 7 January 2021
- journal article
- research article
- Published by Hindawi Limited in Journal of Oncology
- Vol. 2021, 1-20
- https://doi.org/10.1155/2021/8895330
Abstract
Urine can accumulate systemic changes with no mechanism to be stable, which may reflect early changes associated with physiological or pathophysiological processes. To explore the potential value of the urine proteome, two rat models were established by intrahepatic injection of two different hepatoma cell lines, CBRH-7919 and RH-35. Urine samples were collected and analyzed. Compared with controls, the two models exhibited different numbers and types of differentially expressed urinary proteins despite having similar histological results. The results were compared with the urine proteome of a Walker 256 (W-256) liver tumor model. The differentially expressed urinary protein patterns in the three models were different. These findings demonstrate that changes in the urine proteomes of the two models can be detected at early stages and that the patterns of differentially expressed urinary proteins can differ even when the histological results are similar. Urinary proteins have potential utility for distinguishing among different tumor cells grown in the same organ.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (2020KJZX002, 2018YFC0910202, 2016 YFC 1306300, 110651103, 7172076, 2016-2.27, 11100704)
This publication has 53 references indexed in Scilit:
- Development of Biomarkers for Screening Hepatocellular Carcinoma Using Global Data Mining and Multiple Reaction MonitoringPLOS ONE, 2013
- Role of the Nrf2-ARE Pathway in Liver DiseasesOxidative Medicine and Cellular Longevity, 2013
- Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular CarcinomaGastroenterology Research and Practice, 2013
- LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinomaEuropean Journal of Cancer, 2012
- The power and pitfalls of IL-12Blood, 2012
- Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samplesCancer Letters, 2011
- Expression of deleted in malignant brain tumours 1 (DMBT1) relates to the proliferation and malignant transformation of hepatic progenitor cells in hepatitis B virus‐related liver diseasesHistopathology, 2011
- Universal sample preparation method for proteome analysisNature Methods, 2009
- Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinomaInternational Journal of Cancer, 2005
- Clinical evaluation of serum guanase activity in liver diseasesClinical Biochemistry, 1984